ProKidney Corp’s recent filing unveils that its Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital acquired Company’s shares for reported $0.28 million on Apr 22 ’25. In the deal valued at $0.71 per share,387,393 shares were bought. As a result of this transaction, Control Empresarial de Capital now holds 73,842,723 shares worth roughly $72.37 million.
Then, Control Empresarial de Capital bought 25,000 shares, generating $18,690 in total proceeds. Upon buying the shares at $0.75, the Add’l Rep. Persons-see Ex.99-1 now owns 73,455,330 shares.
Before that, Control Empresarial de Capital bought 100,000 shares. ProKidney Corp shares valued at $74,820 were divested by the Add’l Rep. Persons-see Ex.99-1 at a price of $0.75 per share. As a result of the transaction, Control Empresarial de Capital now holds 73,430,330 shares, worth roughly $71.96 million.
JP Morgan initiated its ProKidney Corp [PROK] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. BofA Securities revised its rating on January 02, 2024. It rated PROK as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PROK
On Friday, ProKidney Corp [NASDAQ:PROK] saw its stock jump 24.22% to $0.98. Over the last five days, the stock has gained 35.25%. ProKidney Corp shares have fallen nearly -42.15% since the year began. Nevertheless, the stocks have fallen -69.55% over the past one year. While a 52-week high of $3.81 was reached on 01/06/25, a 52-week low of $0.46 was recorded on 04/09/25. SMA at 50 days reached $0.7830, while 200 days put it at $1.5074.
Levels Of Support And Resistance For PROK Stock
The 24-hour chart illustrates a support level at 0.8589, which if violated will result in even more drops to 0.7402. On the upside, there is a resistance level at 1.0382. A further resistance level may holdings at 1.0988. The Relative Strength Index (RSI) on the 14-day chart is 65.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0813, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 0.84%. Stochastics %K at 65.42% indicates the stock is a holding.
The most recent change occurred on July 25, 2023 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $16 price target.
